The dorsal root ganglia in adrenomyeloneuropathy: Neuronal atrophy and abnormal mitochondria

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 5, 2001, Pages 493-501

  Powers, James M ^a   DeCiero, David P ^a   Cox, Christopher ^a   Richfield, Eric K ^a   Ito, Masumi ^a   Moser, Ann B ^b   Moser, Hugo W ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Dorsal root ganglia; Fatty acids; Mitochondrial inclusions; Myelopathy; Neuronal atrophy; Neurotrophins

Indexed keywords

NEUROTROPHIN;

ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; ATAXIA; ATROPHY; AXOPLASM FLOW; DISORDERS OF PEROXISOMAL FUNCTIONS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MITOCHONDRION; MORPHOMETRICS; NEUROPATHY; PRIORITY JOURNAL; SPASTIC PARESIS; SPINAL CORD; SPINAL CORD DISEASE; SPINAL GANGLION;

EID: 0035005817     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.5.493     Document Type: Article

References (57)

1. Schaumburg HH, Powers JM, Raine CS, et al. Adrenomyeloneuropathy: A probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology 1977;27:1114-19
2. Powers JM, DcCiero DP, Ito M, Moser AB, Moser HW. Adrenomyeloneuropathy: A neuropathologic review featuring its noninflammatory myelopathy. J Neuropathol Exp Neurol 2000;59:89-102
3. Powers JM, DeCiero D, Cox C, et al. The dorsal root ganglia in adrenomyeloneuropathy (AMN). J Neuropathol Exp Neurol 1999; 58:559
4. Budka H, Sluga E, Heiss WD. Spastic paraplegia associated with Addison's disease: Adult variant of adrenoleukodystrophy. J Neurol 1976;213:237-50
5. Shea TB, Majocha RE, Marotta CA, Nixon RA. Soluble, phosphorylated forms of the high molecular weight neurofilament protein in perikarya of cultured neuronal cells. Neuroscience Letters 1988;92:291-97
6. Gelbard HA, James H, Sharer L, et al. Identification of apoptotic neurons in post-mortem brain tissue with HIV-1 encephalitis and progressive enccphalopathy. Neuropathol Appl Neurobiol 1995;21: 208-17
7. Thomas LB, Gates DJ, Richfield EK, O'Brien TF, Schweitzer JB, Steindler DA. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol 1995;133:265-72
8. diSant'Agnese PA, De Messy Jensen KL. Diagnostic electron microscopy on reembedded ("popped off") areas of large spurr epoxy sections. Ultrastruct Pathol 1984;6:247-53
9. Ghadially FN. Intramitochondrial lipidic inclusions.In: Ghadially FN, ed. Ultrastructural pathology of the cell and matrix. Boston: Butterworth-Heinemann, 1997:310-13
10. Ghadially FN. Flocculent or woolly densities in mitochondria.In: Ghadially FN, ed. Ultrastructural pathology of the cell and matrix. Boston: Butterworth-Heinemann, 1997:256-58
11. Powers JM, Moser HW. Peroxisomal disorders: Genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol 1998;8:101-20
12. Goto S, Hirano A. Immunohistochemical evidence for the selective involvement of dorsal root fibres in Friedreich's ataxia. Neuropathol Appl Neurobiol 1990;16:365-70
13. Powers JM. Adreno-leukodystrophy (adreno-testiculo-leuko-myelo-neuropathic-complex). Clin Neuropathol 1985;4:181-99
14. Hughes JT, Brownell B, Hewer RL. The peripheral sensory pathway in Friedreich's ataxia: An examination by light and electron microscopy of the posterior nerve roots, posterior root ganglia, and peripheral sensory nerves in cases of Friedrcich's ataxia. Brain 1968;91:803-18
15. Nachmanoff DB, Segal RA, Dawson DM, Brown RB, De Girolami U. Hereditary ataxia with sensory neuronopathy: Biemond's ataxia. Neurology 1997;48:273-75
16. Hughes JT, Brownell B. Pathology of peroneal muscular atrophy (Charcot-Marie-Tooth disease). J Neurol, Neurosurg, Psychiat 1972;35:648-57
17. Nagano I, Shapshak P, Yoshioka M, Xin KQ, Nakamura S, Bradley WG. Parvalbumin and calbindin D-28 k immunoreactivity in dorsal root ganglia in acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol 1996;22:293-301
18. Ernfors P, Lee K-F, Kucera J, Jaenisch R. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994;77:503-12
19. Mu X, Silos-Santiago I, Carroll SL, Snider WD. Neurotrophin receptor genes are expressed in distinct patterns in developing dorsal root ganglia. J Neuroscience 1993;13:4029-41
20. McMahon SB, Armanini MP, Ling LH, Phillips HS. Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 1994;12:1161-71
21. Mendell LM. Neurotrophins and sensory neurons: Role in development, maintenance, and injury. A thematic summary. Phil Trans R Soc Lond B: Biol Sci 1996;351:463-67
22. Snider WD, Silos-Santiago I. Dorsal root ganglion neurons require functional neurotrophin receptors for survival during development. Phil Trans R Soc Lond B: Biol Sci 1996;351:395-403
23. Walsh TJ, Clark AW, Parnad IM, Green WR. Neurotoxic effects of cisplatin therapy. Arch Neurol 1982;39:719-20
24. Krarup-Hansen A, Rietz B, Krarup C, Heydorn K, Rørth M, Schmalbrucht H. Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: An autopsy study. Neuropathol Appl Neurobiol 1999;25:29-40
25. Tomiwa K, Nolan C, Cavanagh JB. The effects of cisplatin on rat spinal ganglia: A study by light and electron microscopy and by morphometry. Acta Neuropathol 1986;69:295-308
26. Cavaletti G, Tredici G, Marmiroli P, Petruccioli MG, Barajon I, Fabbrica D. Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol 1992;84:364-71
27. Barajon I, Bersani M, Quartu M, et al. Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy. Exp Neurol 1996;138:93-104
28. Gao WQ, Dybdal N, Shinsky N, et al. Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy. Ann Neurol 1995;38:30-37
29. Windelbank AJ. Cisplatin.In: Spencer PS, Schaumburg HH, eds. Experimental and clinical neurotoxicology. New York: Oxford University Press, 2000:392-96
30. Koga M, Oyanagi S, Oyake Y. Pseudo-intracellular collagen tangles in human spinal ganglia. Neuropathol Appl Neurobiol 1979;5:225-32
31. Scaravilli F, Giometto B, Chimelli L, Sinclair E. Macrophages in human sensory ganglia: An immunohistochemical and ultrastructural study. J Neurocytol 1991;20:609-24
32. Pick J, DeLemos C, Gerdin C. The fine structure of sympathetic neurons in man. J Comp Neurol 1964;122:19-68
33. Gansler H. Elektronenmikroskopische untersuchungen von menschlichen operations-material.In: Sjöstrand FS, Rhodin J, eds. Proc Stockholm Conf Electron Microscopy. Uppsala: Almquist and Wiksell, 1957:190-91
34. Cravioto H. Elektronenmikroskopische untersuchungen am sympathischen nerven system des menschen. Z Zellforsch u mikr Anat 1962;58:312-30
35. Lloreta-Trull J. Biology and pathology of the mitochondrion. Ultrastructural Pathol 1998;22:357-67
36. Hirano A, Llena JF, French JH, Ghatak NR. Fine structure of the cerebellar cortex in Menkes kinky-hair disease. X-chromosome-linked copper malabsorption. Arch Neurol 1977;34:52-56
37. Yoshimura N, Kudo H. Mitochondrial abnormalities in Menkes' kinky hair disease (MKHD). Electron-microscopic study of the brain from an autopsy case. Acta Neuropathol (Berl) 1983;59:295-303
38. Brenner O, de Lahunta A, Cummings JF, Summers BA, Monachelli M. A canine encephalomyelopathy with morphological abnormalities in mitochondria. Acta Neuropathol 1997;94:390-97
39. IIe 4269 mutation): Histochemical, immunohistochemical, and ultrastructural study. J Neurol Sci 1995;131:170-76
40. Moser HW, Naidu S, Kumar AJ, Rosenbaum AE. The adrenoleukodystrophies. CRC Critical Review Neurohiol 1987;3:29-88
41. Aubourg P. X-linked adrenoleukodystrophy.In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol. 66. Moser HW, ed. Amsterdam: Elsevier, 1996:447-83
42. Moser HW. Adrenoleukodystrophy: Phenotype, genetics, pathogenesis, and therapy. Brain 1997;120:1485-1508
43. Moser HW, Powers JM, Smith KD. Adrenoleukodystrophy: Molecular genetics, pathology, and Lorenzo's oil. Brain Pathol 1995;5: 259-66
44. Smith KD, Kemp S, Braiterman LT, et al. X-linked adrenoleukodystrophy: Genes, mutations, and phenotypes. Neurochem Res 1999;24:521-55
45. Moser HW, Moser AB, Smith KD, et al. Adrenoleukodystrophy: Phenotypic variability and implications for therapy. J Inher Metab Dis 1992;15:645-64
46. Tsuji S, Sano T, Ariga T, Miyatake T. Increased synthesis of hexacosanoic acid (C23:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). J Biochem (Tokyo) 1981;90:1233-36
47. Goldfischer S, Moore CL, Johnson AB, et al. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science 1973;182:62-64
48. Wanders RJA, Tager JM. Lipid metabolism in peroxisomes in relation to human disease. Molecular Aspects Med 1998;19:71-154
49. Powers JM, Schaumburg HH, Johnson AB, Raine CS. A correlative study of the adrenal cortex in adreno-leukodystrophy - Evidence for a fatal intoxication with very long chain saturated fatty acids. Invest Cell Pathol 1980;3:353-76
50. Allen JP, Kepic T, Garwicki D, Yunus M. Adrenal defect in adrenomyelodystrophy. South Med J 1982;75:877-79
51. Mutoh T, Tokuda A, Miyadai T, Hamaguchi M, Fujiki N. Ganglioside GM1 binds to the Trk protein and regulates receptor function. Proc Natl Acad Sci USA 1995;92:5087-91
52. Gorin PD, Johnson Jr EM. Effects of long-term nerve growth factor deprivation on the nervous system of the adult rat: An experimental autoimmune approach. Brain Res 1980;198:27-42
53. Gold BG, Mohley WC, Matheson SF. Regulation of axonal caliber, neurofilament content and nuclear localization in mature sensory neurons by nerve growth factor. J Neuroscience 1991;11:943-55
54. Rasmussen M, Moser AB, Borel J, Khangoora S, Moser HW. Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil). Neurochem Res 1994;19:1073-82
55. Mayer M, Noble M. N-Acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro. Proc Natl Acad Sci USA 1994;91:7496-7500
56. 4 9 on neural transport in cisplatin induced neurotoxicity. Brain Res 1995;676:258-67
57. Cavaletti G, Cascinu S, Venturino P, Tedeschi M, Tredici G. Neuroprotectant drugs in cisplatin neurotoxicity. Anticancer Res 1996; 16:3149-60